Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARL14EP divergent transcript (ARL14EP-DT)
- Target
- ARL14EP-DT
- Molecular classification
- Other (noncoding RNA, transcriptome annotation)
01
Overview
ARL14EP divergent transcript (ARL14EP-DT) is a genomically annotated noncoding RNA transcript arising from bidirectional (divergent) transcription at the ARL14EP locus. Divergent transcripts are typically unstable, carry no coding information, and are not functionally characterized. There is no evidence for ARL14EP-DT as a pharmacological, clinical, or experimental target. The bona fide gene product, ARF Like GTPase 14 Effector Protein (ARL14EP), interacts with ARL14 and MYO1E to regulate major histocompatibility class II vesicle trafficking in dendritic cells, but ARL14EP-DT itself lacks confirmed function or disease association[1][2][3][4].
- Other names
- ARL14EP-DTARL14EP divergent transcript
02
Mechanism of action
None
03
Biological functions
Other (divergent transcription may play a role in genome evolution and regulation, but specific functions of ARL14EP-DT are unknown)
04
Disease associations
Other (no direct evidence of disease association for ARL14EP-DT; diseases linked to ARL14EP include Seckel Syndrome and Autism Spectrum Disorder, but these refer to the coding gene)
Beyond the preview
Go deeper on ARL14EP divergent transcript (ARL14EP-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARL14EP divergent transcript (ARL14EP-DT).